Omeprazol Hexal (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Hexal, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Omeprazol Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Hexal is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the disorder. - Helicobacter pylori eradication regimens: used as adjunctive therapy to improve eradication rates when combined with antibiotics. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory drug therapy.

Omeprazol Hexal may cause a range of adverse reactions. Most are mild and resolve after discontinuation or continued therapy.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhoea: loose stools occurring during early weeks of therapy. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements in some users.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis associated with altered gut flora. - Osteoporotic fractures: increased risk of hip, wrist or vertebral fractures with long‑term use. - Acute interstitial nephritis: sudden kidney inflammation presenting with rash and renal impairment. - Hypomagnesemia: low serum magnesium levels that may cause muscle cramps or cardiac arrhythmia. - Stevens‑Johnson syndrome: rare severe skin reaction requiring immediate medical attention. - Liver enzyme elevation: abnormal liver function tests indicating possible hepatic stress.

Before starting Omeprazol Hexal, consider the following safety points: - Assess renal function: evaluate kidney health, especially in patients with chronic kidney disease. - Review hepatic status: adjust use if significant liver impairment is present. - Monitor long‑term use: limit duration when possible to reduce fracture risk. - Evaluate pregnancy status: discuss potential risks and benefits with a healthcare professional. - Consider drug interactions: check concomitant medications for possible PK/PD effects. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular event risk. - Atazanavir: markedly decreased absorption of the antiviral, compromising HIV treatment. - Dasatinib: lowered plasma concentrations, potentially reducing anticancer efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, requiring INR monitoring. - Phenytoin: increased metabolism ; may    - Methotrex  -   -   -  t   t

---

---  

---  """"  " """""""""""""""""""""""""""""""""""""""""""""

---  """"""""""" ---  """ --- label --- "" --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ""

--- 

---

"""""" --- 

""" The  t

t

"

"".

--- 

" 

".

".

"".

""